Viruses (Jun 2023)

Hantavirus in Panama: Twenty Years of Epidemiological Surveillance Experience

  • Blas Armién,
  • Carlos Muñoz,
  • Hector Cedeño,
  • Jacqueline R. Salazar,
  • Tybbyssay P. Salinas,
  • Publio González,
  • José Trujillo,
  • Deyanira Sánchez,
  • Jamileth Mariñas,
  • Ayvar Hernández,
  • Harmodio Cruz,
  • Leisy Yovany Villarreal,
  • Elba Grimaldo,
  • Samuel González,
  • Heydy Nuñez,
  • Susana Hesse,
  • Fernando Rivera,
  • George Edwards,
  • Ricardo Chong,
  • Ovidio Mendoza,
  • Martín Meza,
  • Milagro Herrera,
  • Rudick Kant,
  • Raul Esquivel,
  • Dora Estripeaut,
  • Demetrio Serracín,
  • Bernardino Denis,
  • Esthefani Robles,
  • Yaxelis Mendoza,
  • Gloria Gonzalez,
  • Felicia Tulloch,
  • Juan Miguel Pascale,
  • Jonathan L. Dunnum,
  • Joseph A. Cook,
  • Anibal G. Armién,
  • Fernando Gracia,
  • Gladys Alicia Guerrero,
  • Itza de Mosca

DOI
https://doi.org/10.3390/v15061395
Journal volume & issue
Vol. 15, no. 6
p. 1395

Abstract

Read online

Twenty years have passed since the emergence of hantavirus zoonosis in Panama at the beginning of this millennium. We provide an overview of epidemiological surveillance of hantavirus disease (hantavirus pulmonary syndrome and hantavirus fever) during the period 1999–2019 by including all reported and confirmed cases according to the case definition established by the health authority. Our findings reveal that hantavirus disease is a low-frequency disease, affecting primarily young people, with a relatively low case-fatality rate compared to other hantaviruses in the Americas (e.g., ANDV and SNV). It presents an annual variation with peaks every 4–5 years and an interannual variation influenced by agricultural activities. Hantavirus disease is endemic in about 27% of Panama, which corresponds to agroecological conditions that favor the population dynamics of the rodent host, Oligoryzomys costaricensis and the virus (Choclo orthohantavirus) responsible for hantavirus disease. However, this does not rule out the existence of other endemic areas to be characterized. Undoubtedly, decentralization of the laboratory test and dissemination of evidence-based surveillance guidelines and regulations have standardized and improved diagnosis, notification at the level of the primary care system, and management in intensive care units nationwide.

Keywords